Location History:
- Kalamazoo, MI (US) (1997 - 1999)
- Scotts, MI (US) (1999 - 2001)
Company Filing History:
Years Active: 1997-2001
Title: Franklin B. Shilliday: Innovator in Antibiotic Development
Introduction
Franklin B. Shilliday is a notable inventor based in Kalamazoo, MI (US), recognized for his contributions to the field of antibiotics. He holds a total of five patents, showcasing his innovative spirit and dedication to advancing medical science.
Latest Patents
Among his latest patents are Antibiotic 10381A and the process for the preparation of Antibiotics 10381B. Antibiotic 10381A is a cytosine-containing antibiotic that can be produced by culturing a novel microorganism in an aqueous medium and isolating it. This antibiotic inhibits the growth of selected species of yeast, fungi, and bacteria. Additionally, derivatives of Antibiotic 10381A, where R is a C1 to C3 alkyl ester, are also disclosed, along with the pharmaceutically acceptable salts of both the native and esterified forms. Antibiotic 10381B relates to a novel process for its preparation and a method of using it to promote growth in meat-producing animals. These antibiotics are obtained through the fermentation of a nutrient medium with the novel microorganism and are effective against selected species of bacteria.
Career Highlights
Franklin B. Shilliday has worked with prominent companies such as Pharmacia & Upjohn Company and The Upjohn Company. His work has significantly impacted the development of antibiotics, contributing to advancements in medical treatments.
Collaborations
Throughout his career, Shilliday has collaborated with notable individuals, including Alice L. Laborde and Scott E. Truesdell. These collaborations have likely enriched his research and development efforts in the field of antibiotics.
Conclusion
Franklin B. Shilliday's innovative work in antibiotic development has made a lasting impact on the medical field. His patents and collaborations reflect his commitment to advancing healthcare through scientific research.